Influence of incubation time, inoculum size, and glucose concentrations on spectrophotometric endpoint determinations for amphotericin B, fluconazole, and itraconazole

Journal of Clinical Microbiology

Volumn 37, Issue 1, 1999, Pages 141-145

  Nguyen, M Hong ^a   Yu, Christine Y ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; GLUCOSE; ITRACONAZOLE;

ARTICLE; CANDIDA; COLONY FORMING UNIT; CONTROLLED STUDY; CULTURE MEDIUM; DRUG SENSITIVITY; FUNGUS GROWTH; INCUBATION TIME; INOCULATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

CANDIDA; FUNGI;

EID: 0032899858     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.1.141-145.1999     Document Type: Article

References (17)

1. Barchiesi, F., M. Del Poeta, V. Morbiducci, F. Ancarani, and G. Scalise. 1993. Turbidimetric and visual criteria for determining the in vitro activity of six antifungal agents against Candida spp. and Cryptococcus neoformans. Mycopathologia 124:19-25.
2. Barchiesi, F., A. L. Colombo, D. A. McGough, and M. G. Rinaldi. 1994. Comparative study of hroth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard. J. Clin. Microbiol. 32:2494-2500.
3. Blanco, M. T., C. Pérez-Giraldo, J. Blanco, F. J. Morán, C. Hurtado, and A. C. Gómez-Garcia. 1992. In vitro studies of activities of some antifungal agents against Candida albicans ATCC 10231 by the turbidimetric method. Antimicrob. Agents Chemother. 36:898-901.
4. Espinel-Ingroff, A., J. L. Rodríguez-Tudela, and J. V. Martínez-Suárez. 1995. Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans. J. Clin. Microbiol. 33:3154-3158.
5. Espinel-Ingroff, A., C. W. Kish, Jr., T. M. Kerkering, R. A. Fromtling, K. Bartizal, J. N. Galgiani, K. Villareal, M. A. Pfaller, T. Gerarden, M. G. Rinaldi, and A. Fothergill. 1992. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J. Clin. Microbiol. 30:3138-3145.
6. National Committee for Clinical Laboratory Standards. 1994. Development of in vitro susceptibility testing criteria and quality control parameters. Approved guideline M27-A. National Committee for Clinical Laboratory Standards. Villanova, Pa.
7. Nguyen, M. H., C. J. Clancy, V. L. Yu, et al. 1998. Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia. J. Infect. Dis. 177:425-430.
8. Nguyen, M. H., J. E. Peacock, Jr., A. J. Morris, et al. 1996. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am. J. Med. 100:617-623.
9. Odds, F. C., L. Vranckx, and F. Woestenborghs. 1995. Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation. Antimicroh. Agents Chemother. 39:2051-2060.
10. Pfaller, M. A., S. A. Messer, and S. Coffman. 1995. Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870. J. Clin. Microbiol. 33:1094-1097.
11. Pfaller, M. A., C. Grant, V. Morthland, and J. Rhine-Chalberg. 1994. Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans. J. Clin. Microbiol. 32:506-509.
12. Rex, J. H., M. A. Pfaller, J. N. Galgiani, et al. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro and in vivo correlation data for fluconazole, itraconazole, and candida infections. Clin. Infect. Dis. 24:235-247.
13. Rex, J. H., M. A. Pfaller, M. G. Rinaldi, A. Polak, and J. N. Galgiani. 1993. Antifungal susceptibility testing. Clin. Microbiol. Rev. 6:367-381.
14. Rodriguez-Tudela, J. L., and J. V. Martinez-Suarez. 1944. Improved medium for fluconazole susceptibility testing of Candida albicans. Antimicrob. Agents Chemother. 38:45-48.
15. Rodriguez-Tudela, J. L., and J. V. Martinez-Suarez. 1995. Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria. J. Antimicrob. Chemother. 35:739-749.
16. Rodríguez-Tudela, J. L., J. Berenguer, J. V. Martínez-Suárez, and R. Sanchez. 1996. Comparison of a spectropholometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans. Antimicrob. Agents Chemother. 40:1998-2003.
17. Tornatore, M. A., G. A. Noskin, D. M. Hacek, A. A. Obias, and L. R. Peterson. 1997. Effects of incubation time and buffer concentration on in vitro activities of antifungal agents against Candida albicans. J. Clin. Microbiol. 35:1473-1476.